...
机译:急性淋巴细胞白血病中MIR22的基因沉默涉及组蛋白修饰,独立于启动子DNA甲基化
Institute of Hematology, Union Hospital, Wuhan, China|Department of Medical Microbiology and Immunology, Creighton University Medical Center, Omaha, NE;
|Institute of Hematology, Union Hospital, Wuhan, China|Department of Medical Microbiology and Immunology, Creighton University Medical Center, Omaha, NE;
|Department of Medical Microbiology and Immunology, Creighton University Medical Center, Omaha, NE;
Burnham Institute for Medical Research, La Jolla, CA, USA;
Institute of Hematology, Union Hospital, Wuhan, China;
Department of Medical Microbiology and Immunology, Creighton University Medical Center, Omaha, NE;
microRNAs; epigenetics; microRNA-22; histone modification; DNA methylation;
机译:急性淋巴细胞白血病中MIR22的基因沉默涉及独立于启动子DNA甲基化的组蛋白修饰。
机译:高双倍体急性淋巴细胞白血病中存在和不存在转录沉默的情况下,肿瘤抑制基因启动子的甲基化。
机译:组蛋白H3赖氨酸27三甲基化使癌症中的基因沉默,而与启动子DNA甲基化无关。
机译:推论不同组蛋白修饰,DNA甲基化和基因表达之间的因果关系
机译:组蛋白H2B中的特定残基调节酵母基因表达和沉默,组蛋白H3甲基化以及对DNA损伤的反应
机译:致密双等位基因启动子甲基化沉默TESTIN是儿童急性淋巴细胞白血病最常见的分子事件
机译:在高二倍体急性淋巴细胞白血病中存在和不存在转录沉默时肿瘤抑制基因启动子的甲基化